Last Posted: Nov 01, 2018
- Application of Cell-free DNA Analysis to Cancer Treatment.
Corcoran Ryan B et al. The New England journal of medicine 2018 Nov (18) 1754-1765 - Preferred end coordinates and somatic variants as signatures of circulating tumor DNA associated with hepatocellular carcinoma.
Jiang Peiyong et al. Proceedings of the National Academy of Sciences of the United States of America 2018 Oct - Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management.
Elazezy Maha et al. Computational and structural biotechnology journal 2018 16370-378 - Liquid-biopsy microRNA biomarkers to predict risk for diabetic kidney disease
Madras Diabetes Research Foundation, October 29, 2018 - Circulating cell-free DNA- diagnostic and prognostic applications in personalized cancer therapy.
Oellerich M et al. Therapeutic drug monitoring 2018 Oct - Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies.
Gorgannezhad Lena et al. Lab on a chip 2018 18(8) 1174-1196 - Evaluation of a novel liquid biopsy-based ColoScape assay for mutational analysis of colorectal neoplasia and triage of FIT+ patients: a pilot study.
Scimia Mauro et al. Journal of clinical pathology 2018 Oct - Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy.
Panditharatna Eshini et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Oct - Plasma vs Tissue Next-Generation Sequencing in Non–Small Cell Lung Cancer—Either, Both, or Neither?
B Gyawali et al, JAMA Oncology, October 11, 2018 - Circulating tumor DNA (ctDNA) in the era of personalized cancer therapy.
Khatami Fatemeh et al. Journal of diabetes and metabolic disorders 2018 Jun 17(1) 19-30
.png)
No hay comentarios:
Publicar un comentario